Avantel Board Meeting Outcome
Avantel board approved MOA alteration adding medical, space, energy, and AI objects, and a merger of WOS Imeds Global into the parent. No shares will be allotted under the scheme.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Avantel board approved MOA alteration adding medical, space, energy, and AI objects, and a merger of WOS Imeds Global into the parent. No shares will be allotted under the scheme.
Avantel Limited's board approved the appointment of Dr. Tamilmani Kandasamy and Mr. Lakshminarasimha Acharyulu Muktevi as Independent Directors for five-year terms. The company also appointed M/s. Grandhy & Co. as Statutory Auditors for five years, alongside new Internal and Cost Auditors, strengthening its corporate governance and advisory framework.
Avantel Limited has scheduled a Board Meeting on April 26, 2026, to consider and approve audited standalone and consolidated financial results for FY2026. The board will also propose a final dividend and fix the date for the 36th AGM. The trading window remains closed from April 1 until 48 hours after the results are public.